Inventor · disambiguated record
Katherine S. Bowdish
Also filed as: BOWDISH KATHERINE · BOWDISH KATHERINE S
27 granted patents·34 pending applications·487 citations·filing 2001–2015
97Inventor score
Files withALEXION PHARMA INC23BOWDISH KATHERINE S21ANAPHORE INC3PERMEON BIOLOG INC3BOWDISH KATHERINE1
Top patents by PatentIndex Score
61 records- 0196US8114403B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2010·Granted Feb 14, 2012·23 cites·3 claims
- 0295US8840885B2Methods for treating chronic lymphocytic leukemiaBOWDISH KATHERINE S·Filed 2011·Granted Sep 23, 2014·12 cites·5 claims
- 0395US7435412B2Chronic lymphocytic leukemia cell lineALEXION PHARMA INC·Filed 2003·Granted Oct 14, 2008·34 cites·15 claims
- 0494US8075884B2Antibodies to OX-2/CD200 and uses thereofBOWDISH KATHERINE S·Filed 2007·Granted Dec 13, 2011·41 cites·26 claims
- 0594US7408041B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2004·Granted Aug 5, 2008·39 cites·16 claims
- 0693US8709415B2Antibodies to OX-2/CD200 and uses thereofBOWDISH KATHERINE S·Filed 2011·Granted Apr 29, 2014·24 cites·42 claims
- 0793US7396917B2Rationally designed antibodiesALEXION PHARMA INC·Filed 2002·Granted Jul 8, 2008·46 cites·65 claims
- 0893US7306906B2Engineered templates and their use in single primer amplificationALEXION PHARMA INC·Filed 2002·Granted Dec 11, 2007·123 cites·28 claims
- 0991US7915000B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2007·Granted Mar 29, 2011·11 cites·9 claims
- 1091USRE41365ENested oligonucleotides containing a hairpin for nucleic acid amplificationALEXION PHARMA INC·Filed 2009·Granted Jun 1, 2010·15 cites·38 claims
- 1191US7598353B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2008·Granted Oct 6, 2009·10 cites·13 claims
- 1290US9150661B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2012·Granted Oct 6, 2015·7 cites·7 claims
- 1390US8999328B2Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2011·Granted Apr 7, 2015·7 cites·2 claims
- 1490US8187877B2Chronic lymphocytic leukemia cell lineBOWDISH KATHERINE S·Filed 2008·Granted May 29, 2012·7 cites·1 claims
- 1588US7714110B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2008·Granted May 11, 2010·8 cites·17 claims
- 1687US7482435B2Rationally designed antibodiesALEXION PHARMA INC·Filed 2001·Granted Jan 27, 2009·20 cites·53 claims
- 1786US7427665B2Chronic lymphocytic leukemia cell lineALEXION PHARMA INC·Filed 2001·Granted Sep 23, 2008·20 cites·9 claims
- 1885US9000133B2Antibodies to OX-2/CD200 and uses thereofALEXION PHARMA INC·Filed 2013·Granted Apr 7, 2015·6 cites·30 claims
- 1983US7414111B2Engineered templates and their use in single primer amplificationALEXION PHARMA INC·Filed 2003·Granted Aug 19, 2008·10 cites·2 claims
- 2081US8771932B2Rationally designed antibodiesBOWDISH KATHERINE S·Filed 2009·Granted Jul 8, 2014·1 cites·20 claims
- 2181US6919189B2Nested oligonucleotides containing a hairpin for nucleic acid amplificationALEXION PHARMA INC·Filed 2001·Granted Jul 19, 2005·11 cites·38 claims
- 2276US6803230B2Phagemid vectorsALEXION PHARMA INC·Filed 2002·Granted Oct 12, 2004·6 cites·9 claims
- 2367US9249229B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2004·Granted Feb 2, 2016·6 cites·15 claims
- 2465US9409964B2Rationally designed antibodiesALEXION PHARMA INC·Filed 2014·Granted Aug 9, 2016·0 cites·13 claims
- 2564US2006280679A1Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cellsBOWDISH KATHERINE S·Filed 2004·Application pending·0 cites
- 2663US8674082B2Rationally designed antibodiesBOWDISH KATHERINE S·Filed 2008·Granted Mar 18, 2014·0 cites·35 claims
- 2762USRE42130EPhagemid vectorsALEXION PHARMA INC·Filed 2007·Granted Feb 8, 2011·0 cites·9 claims
- 2859US2004101886A1Nested oligonucleotides containing a hairpin for nucleic acid amplificationFiled 2003·Application pending·0 cites
- 2957US2010105620A1Polypeptides that bind Trail-R1 and Trail-R2ANAPHORE INC·Filed 2009·Application pending·0 cites
- 3057US2006057651A1Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2005·Application pending·0 cites
- 3156US2007054378A1Elicitation of antibodies to self peptides in mice by immunization with dendritic cellsALEXION PHARMA INC·Filed 2004·Application pending·0 cites
- 3255US2005208627A1Elicitation of antibodies to self peptides in mice by immunization with dendritic cellsBOWDISH KATHERINE S·Filed 2004·Application pending·0 cites
- 3355US2009011471A1Engineered plasmids and their use for in situ production of genesALEXION PHARMA INC·Filed 2007·Application pending·0 cites
- 3453US2006257412A1Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cellsBOWDISH KATHERINE S·Filed 2004·Application pending·0 cites
- 3553US2004198661A1Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofFiled 2003·Application pending·0 cites
- 3653US2007009957A1Vectors used to create hybrid constant regionsALEXION PHARMA INC·Filed 2004·Application pending·0 cites
- 3751US2012107301A1Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cellsBOWDISH KATHERINE S·Filed 2011·Application pending·0 cites
- 3851US2004253242A1Rationally designed antibodiesFiled 2003·Application pending·0 cites
- 3951US2015368341A1Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2015·Application pending·0 cites
- 4050US2004258699A1Immunotherapeutics for biodefenseFiled 2003·Application pending·0 cites
- 4150US2005208479A1Human antibodies for use as a therapeutic agent against vaccinia or small poxBOWDISH KATHERINE S·Filed 2003·Application pending·0 cites
- 4250US2003049731A1Engineered plasmids and their use for in situ production of genesFiled 2001·Application pending·0 cites
- 4349US2004009178A1Immunotherapeutics for biodefenseFiled 2003·Application pending·0 cites
- 4449US2003219839A1Anti-PDGF antibodies and methods for producing engineered antibodiesFiled 2002·Application pending·0 cites
- 4549US2004180403A1Novel 33 phage vectorsFiled 2002·Application pending·0 cites
- 4648US2008025913A1Novel Anti-Dc-Sign AntibodiesBOWDISH KATHERINE S·Filed 2004·Application pending·0 cites
- 4747US2008152648A1Compositions and methods for enhancing an adjuvantALEXION PHARMA INC·Filed 2007·Application pending·0 cites
- 4845US2004197911A1Novel 88 phage vectorsFiled 2002·Application pending·0 cites
- 4945US2012135938A1Polypeptides that Bind TRAIL-R1 and TRAIL-R2BOWDISH KATHERINE S·Filed 2012·Application pending·0 cites
- 5044US2008008719A1Methods and compositions for the treatment of prostate cancerBOWDISH KATHERINE S·Filed 2007·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Katherine S. Bowdish files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →